Heritable Human Genome Editing Is Not Inevitable
By Donna Dickenson, Katie Hasson & Marcy Darnovsky,
Project Syndicate
| 03. 17. 2020
In recent years, the consensus barring genetic changes that would be passed down to a person’s every descendant has collapsed, and scientists and bioethicists now focus largely on creating a detailed roadmap for moving forward. But there's a strong case to be made that the previous consensus was correct.
The announcement by the Chinese biophysicist He Jiankui in November 2018 that he had created the world’s first gene-edited babies – an egregious ethical and legal breach that resulted in a three-year prison sentence – gave discussions about heritable human genome editing a new sense of urgency. But those discussions are fundamentally flawed. Given the stakes – for today’s societies and future generations – a course correction is urgently needed.
Some scientists, futurists, and others assert the inevitability of heritable genome editing – altering embryos or gametes in order to produce genetically engineered children who will pass the changed genes and traits to their own offspring. These proponents seem to assume that, overall, it would probably be a good thing – as long as we wait until the technology is “safe” and apply it under the right circumstances. With this in mind, they have focused largely on creating a detailed roadmap for moving forward.
The organizers of the 2018 International Summit on Human Gene Editing, held just days after He’s announcement, proclaimed that “it is time to define a rigorous...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...